3,252 reports of this reaction
2.6% of all AZITHROMYCIN DIHYDRATE reports
#4 most reported adverse reaction
NAUSEA is the #4 most commonly reported adverse reaction for AZITHROMYCIN DIHYDRATE, manufactured by Aurobindo Pharma Limited. There are 3,252 FDA adverse event reports linking AZITHROMYCIN DIHYDRATE to NAUSEA. This represents approximately 2.6% of all 126,693 adverse event reports for this drug.
Patients taking AZITHROMYCIN DIHYDRATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for AZITHROMYCIN DIHYDRATE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for AZITHROMYCIN DIHYDRATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 3,252 FDA reports for AZITHROMYCIN DIHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 2.6% of all adverse event reports for AZITHROMYCIN DIHYDRATE, making it a notable side effect.
If you experience nausea while taking AZITHROMYCIN DIHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.